Recent Comments

Comment RSS

Arsenic News and Research RSS Feed - Arsenic News and Research

Arsenic is a naturally occurring element widely distributed in the earth’s crust. In the environment, arsenic is combined with oxygen, chlorine, and sulfur to form inorganic arsenic compounds. Arsenic in animals and plants combines with carbon and hydrogen to form organic arsenic compounds.

Breathing high levels of inorganic arsenic can give you a sore throat or irritated lungs.

Ingesting very high levels of arsenic can result in death. Exposure to lower levels can cause nausea and vomiting, decreased production of red and white blood cells, abnormal heart rhythm, damage to blood vessels, and a sensation of “pins and needles” in hands and feet.

Ingesting or breathing low levels of inorganic arsenic for a long time can cause a darkening of the skin and the appearance of small “corns” or “warts” on the palms, soles, and torso.

Medical report showing the devastating impacts of coal on human body released

19. November 2009 03:32
Physicians for Social Responsibility today released a groundbreaking medical report, "Coal's Assault on Human Health," which takes a new look at the devastating impacts of coal on the human body. [More]

Source of arsenic contamination of drinking water in Bangladesh found by MIT researchers

16. November 2009 06:05
Researchers in MIT's Department of Civil and Environmental Engineering believe they have pinpointed a pathway by which arsenic may be contaminating the drinking water in Bangladesh, a phenomenon that has puzzled scientists, world health agencies and the Bangladeshi government for nearly 30 years. The research suggests that human alteration to the landscape, the construction of villages with ponds, and the adoption of irrigated agriculture are responsible for the current pattern of arsenic concentration underground. [More]

Posted in: Miscellaneous News

Tags: , ,

CytRx reports financial results for the three months and nine months ended September 30, 2009

9. November 2009 09:17
CytRx Corporation, a biopharmaceutical company, today reported financial results for the three months and nine months ended September 30, 2009. [More]

Positive interim data from the multicenter randomized Phase II trial of palifosfamide presented

6. November 2009 07:38
ZIOPHARM Oncology, Inc. presented today at the 15th Annual Connective Tissue Oncology Society (CTOS) Meeting, positive interim data from the multicenter randomized Phase II trial of palifosfamide (ZymafosTM, ZIO-201) treating patients with unresectable or metastatic soft tissue sarcoma. [More]

TREANDA induces durable responses in indolent B-cell non-Hodgkin's lymphoma patients

6. November 2009 02:05
Cephalon, Inc. today announced the journal Cancer has published a pivotal study demonstrating that TREANDA® (bendamustine HCl) for Injection induced durable responses in patients with indolent B-cell non-Hodgkin's lymphoma (NHL) whose disease had progressed during or within six months of treatment with rituximab. [More]

NUVIGIL improves wakefulness in patients with excessive sleepiness associated with shift work disorder

3. November 2009 01:31
Cephalon, Inc. today announced that the November issue of Mayo Clinic Proceedings has published data from a pivotal Phase III trial demonstrating that NUVIGIL® (armodafinil) Tablets [C-IV] significantly improved wakefulness throughout the shift in patients with excessive sleepiness associated with shift work disorder (SWD). [More]

Computer model to track contaminated soil distribution in households

29. October 2009 02:27
Where does it come from? Scientists in Arizona are reporting a surprising answer to that question, which has puzzled and perplexed generations of men and women confronted with layers of dust on furniture and floors. Most of indoor dust comes from outdoors. Their report is scheduled for the Nov. 1 issue of ACS' Environmental Science & Technology, a semi-monthly journal. [More]

Posted in: Miscellaneous News

Tags:

More people rely on alternative medicine

27. October 2009 11:34
As consumers look to save money in a tough economy, many turn to alternative health care options. CBS 4 reports: "Health care costs are soaring. Thousands of people are without jobs and without the benefits afforded them. Now, those people are turning to preventative or alternative measures. ... The National Center for Complimentary and Alternative Medicine (NCCAM) shows 38 percent of adults and 12 percent of kids are now using alternative therapies to treat pain. In fact, Americans are now reportedly spending $34 billion a year on alternative therapies" (Demos, 10/26). [More]

Posted in: Healthcare News

Tags: , , , , ,

Cephalon, BDC sign option agreement

26. October 2009 09:15
Cephalon, Inc. and BioAssets Development Corporation (BDC), a privately held biopharmaceutical company, today announced that the companies have signed an agreement that will provide Cephalon with an option to acquire BDC. [More]

Posted in: Business / Finance

Tags: , , , , , , , , , , ,

Women and children important during groundwater arsenic pollution fieldwork, says geologist

24. October 2009 02:02
A Kansas State University geologist and graduate student are finding that the most important tools in their fieldwork on groundwater arsenic pollution are women and children armed with pamphlets and testing kits. [More]

Posted in: Miscellaneous News

Tags: , , , ,

Cephalon announces receipt of a Paragraph IV Certification Notice Letter regarding ANDA

22. October 2009 03:59
Cephalon, Inc. (Nasdaq: CEPH) today announced receipt of a Paragraph IV Certification Notice Letter on October 20, 2009 regarding an Abbreviated New Drug Application (ANDA) submitted to the U.S. Food and Drug Administration (FDA) by Teva Pharmaceuticals USA, Inc. requesting approval to market and sell a generic version of the 50 mg, 100 mg, 150 mg, 200 mg and 250 mg strengths of NUVIGIL® (armodafinil) Tablets [C-IV]. [More]

Posted in: Medical Patent News | Pharmaceutical News

Tags: , , , , , ,

New health initiative focuses on environmentally-associated cancers

22. October 2009 02:57
The Barbara Ann Karmanos Cancer Institute, in cooperation with Blue Cross Blue Shield of Michigan (BCBSM), will launch a targeted health initiative in January 2010 focused on environmentally-associated cancers. [More]

Posted in: Medical Condition News | Healthcare News

Tags: , , , , , , ,

Positive data from ZIOPHARM's palifosfamide sarcoma Phase II trial

14. October 2009 09:16
ZIOPHARM Oncology, Inc. announced today positive top line interim data from the multicenter randomized Phase II trial of palifosfamide (ZymafosTM, ZIO-201) treating patients with unresectable or metastatic soft tissue sarcoma. The analysis evaluated 62 patients treated as of the end of September, with 58 being analyzed. [More]

Is DDT pesticide safe to combat malaria?

14. October 2009 04:11
Malaria risk threatens the life and health of thousands daily. In high-risk areas, including sub-Saharan Africa, malaria-related deaths happen every thirty seconds. [More]

Posted in: Disease/Infection News

Tags: , , ,

Study: Role of genetics and environment in autism spectrum disorders

29. September 2009 23:33
Researchers at The University of Texas Health Science Center at Houston and the University of the West Indies have joined forces to launch a study of Jamaican children that they hope will unlock the secrets of how genetics and environment may interact to cause autism spectrum disorders. [More]

Posted in: Medical Condition News

Tags: , , , ,

News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide.